首页> 外文期刊>Investigative ophthalmology & visual science >Alpha2 adrenergic receptor-mediated modulation of cytosolic Ca++ signals at the inner plexiform layer of the rat retina.
【24h】

Alpha2 adrenergic receptor-mediated modulation of cytosolic Ca++ signals at the inner plexiform layer of the rat retina.

机译:Alpha2肾上腺素能受体介导的大鼠视网膜内丛状层中胞质Ca ++信号的调节。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: Compelling evidence suggests that alpha2 agonists, such as brimonidine, protect retinal ganglion cells (RGCs) from injury in a wide range of animal models. However, the mechanism of action for this protection and the physiological role of the alpha2 adrenergic system in the retina is not well understood. A major goal of this work was to explore the role of the alpha2 adrenergic system in the modulation of cytosolic Ca(2+) signaling at retinal synaptic layers, particularly the inner plexiform layer (IPL), where communication between RGCs and their presynaptic cells takes place. METHODS: Functional Ca(2+) imaging at the inner plexiform layer (IPL) and outer plexiform layer (OPL) of living rat retinal slices was conducted with a high-speed confocal system. The relative changes of cytosolic free Ca(2+) were monitored with the fluorescent Ca(2+) dye fluo-4. The Ca(2+) signal was elicited by membrane depolarization produced by a high K(+) (40 mM) Ringer solution that was delivered rapidly and briefly to the test regions of the retinal slice by a custom-made multichannel local perfusion system. RESULTS: A brief application (8 seconds) of high K(+) Ringer elicited a robust cytosolic Ca(2+) increase at the IPL and OPL. In both cases, this Ca(2+) signal was eliminated by nimodipine, a selective L-type voltage-gated Ca(2+)-channel blocker, or when the extracellular Ca(2+) in the Ringer was replaced with equal molar EGTA. At IPL, the Ca(2+) signal was also suppressed in a dose-dependent manner by brimonidine and other alpha2 receptor agonists, such as medetomidine. The suppressive action of brimonidine and medetomidine was completely blocked by classic alpha2 receptor antagonists, such as yohimbine, rauwolscine, and atipamezole. Interestingly, the alpha2 receptor agonists had no effect on the high K(+) Ringer-elicited cytosolic Ca(2+) signal at OPL. Blocking the N-methyl-d-aspartate (NMDA) type of ionotropic glutamate receptor with D-AP5 attenuated this high K(+)-elicited Ca(2+) signal by approximately 20% at IPL. D-AP5 had no effect on the Ca(2+) signal at OPL. CONCLUSIONS: These findings provide the first direct evidence of alpha2 receptor-mediated modulation of L-type Ca(2+) channel activity in the CNS (the retina is part of the CNS). This alpha2 modulation appears to occur at the IPL but not at the OPL of the retina. These findings suggest that a physiological function of the retinal alpha2 system is the regulation of synaptic transmission at IPL and that brimonidine and other alpha2 agonists may protect RGCs under disease conditions by preventing abnormal elevation of cytosolic free Ca(2+) either in RGCs, in their presynaptic cells, or in both.
机译:目的:有力的证据表明,在各种动物模型中,溴莫尼定等α2激动剂可保护视网膜神经节细胞(RGC)免受损伤。然而,对于这种保护的作用机理以及α2肾上腺素系统在视网膜中的生理作用尚不十分了解。这项工作的主要目的是探索在视网膜突触层,特别是内部丛状层(IPL),其中RGC及其突触前细胞之间的通讯需要进行的胞浆Ca(2+)信号的调制中α2肾上腺素系统的作用。地点。方法:在功能的Ca(2+)成像在活大鼠视网膜切片的内部丛状层(IPL)和外部丛状层(OPL)进行了高速共聚焦系统。用荧光Ca(2+)染料fluo-4监测胞质游离Ca(2+)的相对变化。 Ca(2+)信号是由高K(+)(40 mM)林格溶液产生的膜去极化引起的,该溶液通过定制的多通道局部灌注系统快速且短暂地传递到视网膜切片的测试区域。结果:短暂的应用程序(8秒)高K(+)林格引起了强烈的细胞质Ca(2+)在IPL和OPL的增加。在这两种情况下,该尼古丁(一种选择性的L型电压门控Ca(2+)通道阻滞剂)消除了Ca(2+)信号,或者当林格氏菌中的细胞外Ca(2+)被等摩尔的摩尔取代EGTA。在IPL时,溴莫尼定和其他α2受体激动剂(如美托咪定)也以剂量依赖的方式抑制Ca(2+)信号。溴莫尼定和美托咪定的抑制作用被经典的α2受体拮抗剂(如育亨宾,劳伍斯辛和阿替哌唑)完全阻断。有趣的是,alpha2受体激动剂对OPL高K(+)林格引起的胞浆Ca(2+)信号没有影响。用D-AP5阻断离子型谷氨酸受体的N-甲基-d-天冬氨酸(NMDA)类型,可在IPL处将这种高K(+)引起的Ca(2+)信号衰减约20%。 D-AP5对OPL的Ca(2+)信号没有影响。结论:这些发现提供了中枢神经系统(视网膜是中枢神经系统的一部分)中的α2受体介导的L型Ca(2+)通道活性调节的第一个直接证据。这种alpha2调制似乎发生在IPL处,而不发生在视网膜的OPL处。这些发现表明,视网膜α2系统的生理功能是调节IPL上的突触传递,而溴莫尼定和其他α2激动剂可以通过预防RGCs中的胞浆游离Ca(2+)异常升高来保护疾病条件下的RGCs。它们的突触前细胞,或两者都有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号